Enterprise Value
-16.54M
Cash
21.39M
Avg Qtr Burn
-16.27M
Short % of Float
0.99%
Insider Ownership
2.68%
Institutional Own.
8.39%
Qtr Updated
09/30/23
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ATRC-101 (monoclonal antibody) Details Solid tumor/s | Failed Discontinued |